Alpha-adrenergic agonist

Revision as of 15:53, 27 September 2011 by Matt Pijoan (talk | contribs) (Protected "Alpha-adrenergic agonist": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

An adrenergic alpha-agonist is a drug which selectively stimulates alpha adrenergic receptors. The alpha-adrenergic receptor has two subclasses α1 and α2. Although complete selectivity between receptor agonism is rarely achieved, phenylephrine is an α1 agonist, while clonidine and methyldopa are α2 partial agonists [1].

An example is xylazine.

Alpha-adrenergic agonists are used in the treatment of glaucoma by decreasing the production of aqueous fluid by the ciliary bodies of the eye.

External links


Template:Receptor agonists and antagonists


Template:WikiDoc Sources

  1. Pharmacology (3rd Edition) Rang, Dale and Ritter